Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-07994525 IN PARTICIPANTS WITH ADVANCED MALIGNANCIES

NCT07426757 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07426757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07426757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-07994525 IN PARTICIPANTS WITH ADVANCED MALIGNANCIES
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2026
Completion date
July 10, 2030
Enrollment
120 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, advanced malignancies